Biography
Sisi Liu is an associate in Weil’s Regulatory Transactions Group, and is based in the Washington, D.C. office.
Sisi has been part of the teams advising:
- Aterian Investment Partners in its acquisition of Outlook Group
- CCP Investments in Novolex’s $6.7 billion combination with Pactiv Evergreen
- Emergent BioSolutions Inc. in its $100 million senior secured revolving facility
- EQT Transition Infrastructure in its acquisition of Scale Microgrids
- Hologic Capital Holdings, Inc. in its $350 million acquisition of Gynesonics, Inc.
- Montagu in its acquisition of Tyber Medical and combination with Intech and Resolve
- Underwriters in connection with The Williams Companies $1.5 billion bond offering
- Willis Towers Watson PLC in its $632 million sale of TRANZACT to GTCR and Recognize
Prior to joining Weil, Sisi worked at another major Washington, D.C. based law firm.
Sisi received her J.D. from the University of Maryland Francis King Carey School of Law, and her B.A., cum laude, from the University of Pittsburgh. While in law school, Sisi served as a judicial extern to the Honorable Robert N. McDonald of the Court of Appeals of Maryland.